Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic strategy for managing metabolic syndromes. These naturally occurring molecules are secreted by the gut in response to nutrient intake, stimulating insulin and wholesale BPC capsules production and suppressing glucagon secretion. GLP-1 peptides exhibit promising thera